2.85
Schlusskurs vom Vortag:
$2.81
Offen:
$2.77
24-Stunden-Volumen:
20,761
Relative Volume:
0.89
Marktkapitalisierung:
$15.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.35M
KGV:
-0.9344
EPS:
-3.05
Netto-Cashflow:
$-11.88M
1W Leistung:
+3.26%
1M Leistung:
-2.06%
6M Leistung:
-10.38%
1J Leistung:
-36.53%
Lipocine Inc Stock (LPCN) Company Profile
Firmenname
Lipocine Inc
Sektor
Branche
Telefon
801 994 7383
Adresse
675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, UT
Vergleichen Sie LPCN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
LPCN
Lipocine Inc
|
2.85 | 15.23M | 0 | -16.35M | -11.88M | -3.05 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Lipocine Inc Stock (LPCN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2021-06-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-12-10 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
2018-01-12 | Bestätigt | H.C. Wainwright | Buy |
2018-01-11 | Herabstufung | Canaccord Genuity | Buy → Hold |
2017-12-08 | Fortgesetzt | H.C. Wainwright | Buy |
2016-10-07 | Eingeleitet | H.C. Wainwright | Buy |
2015-07-22 | Eingeleitet | ROTH Capital | Buy |
2015-06-23 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Lipocine Inc Aktie (LPCN) Neueste Nachrichten
Progress Update: LPCN 1154 for the Treatment of Postpartum Depression - Psychiatric Times
Lipocine Advances Phase 3 Trial for PPD Treatment - TipRanks
Lipocine provides progress update on LPCN 1154 Phase 3 clinical - MarketScreener
Lipocine reports one-third enrollment in PPD treatment trial - Investing.com India
Lipocine Provides Progress Update on LPCN 1154 Phase 3 Clinical Trial in Postpartum Depression (PPD) - PR Newswire
How to forecast Lipocine Inc. trends using time seriesAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com
How to track smart money flows in Lipocine Inc.Market Sentiment Summary & High Return Trade Opportunity Guides - newser.com
Is Lipocine Inc a good long term investmentSupport Level Holds & Low Cost Stock Picks - earlytimes.in
Lipocine Seeks Regulatory Clarity on LPCN 2401 Study - The Globe and Mail
Lipocine, Inc. Stock Plummets to New 52-Week Low of $2.65 - Markets Mojo
Lipocine, Inc. Hits New 52-Week Low at $2.68 Amid Declining Sales - Markets Mojo
Will Lipocine Inc. rebound enough to break evenBuy Signal & Expert Curated Trade Ideas - newser.com
Volume spikes in Lipocine Inc. stock – what they meanDividend Hike & Proven Capital Preservation Tips - newser.com
Analyzing recovery setups for Lipocine Inc. investorsLayoff News & Long-Term Growth Stock Strategies - newser.com
Long term hold vs stop loss in Lipocine Inc.Rate Hike & Fast Entry Momentum Trade Alerts - newser.com
Hedge Fund Moves: What are the future prospects of Lipocine IncMarket Risk Report & Capital Protection Trade Alerts - خودرو بانک
Custom watchlist performance reports with Lipocine Inc.Quarterly Market Review & Daily Profit Maximizing Trade Tips - newser.com
Block Trades: What is Lipocine Incs revenue forecast2025 Growth vs Value & AI Enhanced Trade Execution Alerts - خودرو بانک
Signal Recap: Will Lipocine Inc benefit from rate cutsWeekly Stock Report & Long Hold Capital Preservation Tips - خودرو بانک
Earnings Report: Is Lipocine Inc stock trending bullishWeekly Stock Analysis & Accurate Intraday Trade Tips - khodrobank.com
Update Report: Does Lipocine Inc have pricing power2025 Trade Ideas & Daily Chart Pattern Signal Reports - خودرو بانک
Is Lipocine Inc. still worth holding after the dip2025 Institutional Moves & Growth Focused Entry Point Reports - newser.com
What MACD and RSI say about Lipocine Inc.2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com
Can volume confirm reversal in Lipocine Inc.Inflation Watch & Consistent Return Investment Signals - newser.com
What MACD signals say about Lipocine Inc.Trade Ideas & AI Optimized Trading Strategy Guides - newser.com
Trend analysis for Lipocine Inc. this week2025 Bull vs Bear & Smart Allocation Stock Reports - newser.com
Earnings visualization tools for Lipocine Inc.Quarterly Growth Report & Weekly High Return Opportunities - newser.com
Risk Hedge: What drives SS C Technologies Holdings Incs stock priceTrend Reversal & Daily Stock Trend Watchlist - khodrobank.com
Heatmap analysis for Lipocine Inc. and competitorsWeekly Volume Report & Fast Gain Swing Alerts - newser.com
Will Lipocine Inc. outperform the market2025 Investor Takeaways & Expert Verified Movement Alerts - newser.com
does lipocine inc. fit your quant trading modelWeekly Trend Recap & Low Risk Profit Maximizing Plans - newser.com
Does Lipocine Inc. fit your quant trading model2025 Year in Review & Free Expert Verified Stock Movement Alerts - newser.com
Retail Surge: Does Lipocine Inc. have pricing powerBuy Signal & Weekly High Conviction Trade Ideas - خودرو بانک
Technical signs of recovery in Lipocine Inc.Profit Target & Consistent Profit Alerts - newser.com
Weekly Trades: Is Locafy Limited stock a good dividend stock2025 Volume Leaders & Growth-Oriented Investment Plans - خودرو بانک
How sentiment analysis helps forecast Lipocine Inc.July 2025 Market Mood & Precise Swing Trade Entry Alerts - newser.com
Aug Setups: Is Byrna Technologies Inc. vulnerable to short sellersJuly 2025 WrapUp & Community Shared Stock Ideas - خودرو بانک
FOMO Trade: Does Lipocine Inc stock have upside surprise potential2025 Market WrapUp & AI Powered Buy and Sell Recommendations - خودرو بانک
Is Lipocine Inc affected by consumer sentimentJuly 2025 Chart Watch & Real-Time Stock Price Movement Reports - خودرو بانک
Finanzdaten der Lipocine Inc-Aktie (LPCN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):